Allena Pharmaceuticals (NASDAQ:ALNA) Downgraded by Zacks Investment Research to Sell

Allena Pharmaceuticals} stock has undergone multiple analysts rating changes in the recent past.  Allena Pharmaceuticals Downgraded by Zacks Investment Research on 10/14/2021. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

View More Allena Pharmaceuticals (NASDAQ:ALNA) Downgraded by Zacks Investment Research to Sell